Calypso Medical Technologies, the Seattle-based developer of a device to pinpoint radiation therapy for prostate cancer, said today it has formed a partnership with Palo Alto, CA-based Varian Medical Systems, the world’s leading maker of medical devices and software for cancer treatment. The two companies will jointly develop products to incorporate the Calypso technology into Varian’s radiation therapy technologies. Financial terms of the agreement weren’t disclosed.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
